IMEC

The Belgian microelectronics center develops ultra-low-power chips and flexible sensor substrates for next-generation smart medical patches.

Country
Belgium
Coverage
CNEUUS
diagnostics-medtech
Regulatorsfdaemanmpa

Verifiable facts

FactValueSource
Funding€2.5 billion for NanoIC pilot line from Europe, Flanders, and industry partnersdrupal.imec-int.com · egmontinstitute.be
FundingApproximately 75% of annual budget from private sector, 25% from public investment (Flemish government and EU)egmontinstitute.be
CapacityUp to 500-1,000 wafers per year in-house; support for transfer to high-volume foundriesimec-int.com
CertificationISO 9001:2015 for design, research, development, integration, characterization, prototyping, and low-volume production in Leuvenimec-int.com
CertificationEcovadis committed badge leveldrupal.imec-int.com
Regulatory approvalExpertise in regulatory readiness; technologies have gained approvals from agencies such as FDA and PMDAimec-int.com
Production siteLeuven, Belgium (300mm and 200mm cleanrooms); Málaga, Spain (in development)imec-int.com
HeadcountOver 6,600 employees (as of 2025)drupal.imec-int.com · imec-int.com
Revenue€1.034 billion in 2024; €846 million in 2022drupal.imec-int.com

Independent sources: egmontinstitute.be

Technologies
NameClusterRisk
Wearable biodiagnosticsdiagnostics-medtechMedium

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.